InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
T+90 hit rate
22%
T+90 mean return
-11.4%
Across 9 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Bruce David, Chairman & CEO. Director active across 1 company, notably IRIDEX CORP. Cumulatively, 9 filings have been recorded. History available since 30 June 2021. The latest transaction was disclosed on 4 July 2024 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations9 total
4,788 shares@ US$2.0710.2% of flowCommon StockSEC:0000950170-24-082090:0
7,098 shares@ US$2.1615.9% of flowCommon StockSEC:0000950170-24-080782:0
10,112 shares@ US$2.1722.4% of flowCommon StockSEC:0001209191-24-005767:0
59,730 shares0Common StockSEC:0001209191-22-054947:0
3,227 shares@ US$2.578.8% of flowCommon StockSEC:0001209191-22-040504:0
40,260 shares0Common StockSEC:0001209191-21-050497:0
40,260 shares0Common StockSEC:0001209191-21-050497
3,227 shares@ US$7.060.11% mcap50.0% of flowCommon StockSEC:0001209191-21-044989:0
3,227 shares@ US$7.0621.4% of flowCommon StockSEC:0001209191-21-044989
9 of 9 declarations
About Bruce David
David Bruce is the President and CEO of IRIDEX Corp. In this role, he leads the company, which specializes in medical technologies. Mr. Bruce is responsible for strategic direction and operational management, contributing to the company's innovation and growth.
